NCT04138173 is a NA clinical trial of Tele coaching intervention in Interstitial Lung Disease, sponsored by KU Leuven.

Who is sponsoring NCT04138173?

NCT04138173 is sponsored by KU Leuven.

What drugs are being tested in NCT04138173?

Interventions in NCT04138173: Tele coaching intervention.

What condition does NCT04138173 study?

NCT04138173 studies Interstitial Lung Disease, Interstitial Pulmonary Fibrosis.

Is NCT04138173 still recruiting?

NCT04138173 is currently completed. Last updated 18 March 2022.

Last reviewed 2022-03-18 · How we verify

NCT04138173

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enhancing Physical Activity in Patients With Interstitial Lung Disease

Completed NA Last updated 18 March 2022

What this trial tests

NA trial testing Tele coaching intervention in Interstitial Lung Disease in 40 participants. Completed in 6 January 2022.

Timeline

14 January 2020

Primary endpoint
6 January 2022

6 January 2022

Quick facts

Lead sponsor	KU Leuven
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	14 January 2020
Primary completion	6 January 2022
Estimated completion	6 January 2022
Sites	1 location across Belgium

Drugs / interventions tested

Tele coaching intervention

Conditions studied

Interstitial Lung Disease — all drugs for Interstitial Lung Disease →
Interstitial Pulmonary Fibrosis — all drugs for Interstitial Pulmonary Fibrosis →

Sponsor

KU Leuven — full company profile →

Who can join

18 and older, any sex, with Interstitial Lung Disease or Interstitial Pulmonary Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The level of physical activity (PA) has been shown to be an important predictor for morbidity and mortality in patients with chronic respiratory diseases such as COPD and more recently Idiopathic Pulmonary Fibrosis. Physical inactivity is a common feature of patients with chronic respiratory diseases. Whereas pulmonary rehabilitation is known to result in benefits in exercise capacity, symptoms and quality of life, these gains will not automatically translate into increases in physical activity. Therefore, the present study aims to investigate the effect of a physical activity coaching program on the physical activity level of patients with interstitial lung disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Physical activity coaching in patients with interstitial lung diseases: A randomized controlled trial.
Breuls S, Zlamalova T, Raisova K, Blondeel A, et al · · 2024 · cited 8× · PMID 38511242 · DOI 10.1177/14799731241235231

Verify or expand the search:

Other recruiting trials for Interstitial Lung Disease

Currently open trials in the same condition.

NCT07451977 — Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia · NA · recruiting
NCT07254338 — Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific · recruiting
NCT07269262 — SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers · NA · recruiting
NCT07179380 — Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension · Phase 3 · recruiting
NCT07323732 — A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Diseas · Phase 2 · recruiting

Other KU Leuven trials

Trials by the same sponsor.

NCT07508696 — Cerebellar Research in Ultrasound Stimulation · NA · not yet recruiting
NCT07476716 — Peer-modeled Intervention · NA · not yet recruiting
NCT07534384 — Automated CPET Interpretation: International Validation Study · not yet recruiting
NCT07419555 — Belgian Lung Function Study · recruiting
NCT07295600 — Postprandial Effect of Isocaloric Challenge Meals Enriched With Indigenous Fruits and Vegetables on Glucose Metabolism i · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04138173 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by KU Leuven
Last refreshed: 18 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04138173.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing